Quality standard measure: Proportion of people with risk factors for CKD who receive testing
What was measured: Proportion of patients with diabetes whose GP practices tested their serum creatinine levels on an annual basis
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Proportion of people with risk factors for CKD who receive testing
What was measured: Proportion of patients with diabetes whose GP practices tested their urinary albumin/creatinine ratio on an annual basis
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Proportion of people with CKD in defined at‑risk groups who are referred for specialist assessment
What was measured: Proportion of people with CKD in high risk groups who have a specialist referral recorded
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Incidence of cardiovascular events for people with CKD.
What was measured: Hospitalisations due to acute and chronic ischaemic heart disease in people with coded and uncoded CKD stages 3-5.
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Incidence of cardiovascular events for people with CKD.
What was measured: Hospitalisations due to cerebrovascular disease or TIA in people with coded and uncoded CKD stages 3-5.
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Incidence of cardiovascular events for people with CKD.
What was measured: Hospitalisations due to heart failure in people with coded and uncoded CKD stages 3-5.
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Incidence of cardiovascular events for people with CKD.
What was measured: Hospitalisations due to peripheral and aortic artery disease in people with coded and uncoded CKD stages 3-5.
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Proportion of people with higher levels of proteinuria with a recording of blood pressure in the previous 9 months, whose latest systolic blood pressure reading is in the range 120–129 mmHg and diastolic blood pressure below 80 mmHg
What was measured: Proportion of people with CKD stage 3 to 5 with diabetes who had a below target blood pressure reading recorded
Data collection end: June 2016
Area covered: |
England and Wales |
Source: |
National Chronic Kidney Disease Audit. |
Quality standard measure: Proportion of people with CKD who are assessed for disease progression in accordance with current NICE guidance.
What was measured: QOF CKD6: The percentage of patients on the CKD register whose notes have a record of a urine albumin: creatinine ratio (or protein: creatinine ratio) test in the previous 15 months
Data collection end: March 2011
Data collection end: March 2012
Data collection end: March 2013
Area covered: |
National |
Source: |
Health and Social Care Information Centre. Quality and Outcomes Framework. |